Puma Biotechnology | PBYI - Current Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Puma Biotechnology

Puma Biotechnology reported $111.75M in Current Assets for its fiscal quarter ending in March of 2023.


Current Assets Change
Agios Pharmaceuticals AGIO:US USD 791.66M 41.12M
Alnylam Pharmaceuticals ALNY:US USD 2.54B 151.23M
Amgen AMGN:US USD 44.7B 22.52B
Biogen BIIB:US USD 9.76B 28.7M
BioMarin Pharmaceutical BMRN:US USD 2.84B 90.65M
Bluebird Bio BLUE:US USD 351.07M 151.58M
Daiichi Sankyo 4568:JP JPY 1.5T 57.44B
Esperion Therapeutics ESPR:US USD 250.6M 3.92M
Exelixis EXEL:US USD 1.64B 18.86M
Gilead Sciences GILD:US USD 14.37B 855M
Glaxosmithkline GSK:US GBP 19.72B 1.05B
Incyte Corp INCY:US USD 3.97B 121.22M
Intercept Pharmaceuticals ICPT:US USD 490.46M 49.67M
MacroGenics MGNX:US USD 288.94M 66.76M
Mirati Therapeutics MRTX:US USD 939.35M 169.61M
Moderna Inc MRNA:US USD 12.12B 1.31B
Novartis NOVN:VX USD 32.11B 4.8B
PTC Therapeutics PTCT:US USD 613.39M 80.39M
Puma Biotechnology PBYI:US USD 111.75M 22.53M
Regeneron Pharmaceuticals REGN:US USD 16.91B 1.03B
Roche Holding ROG:VX CHF 33.82B 3.5B
Sangamo BioSciences SGMO:US USD 227.09M 73.24M
Sarepta Therapeutics SRPT:US USD 2.49B 69.48M
Seattle Genetics SGEN:US USD 2.6B 200.62M
Spectrum Pharmaceuticals SPPI:US USD 105.38M 4.37M
Takeda 4502:JP JPY 2.4T 197.99B
TG Therapeutics TGTX:US USD 184.78M 16.51M
Ultragenyx Pharmaceutical RARE:US USD 766.34M 117.56M
Vanda Pharmaceuticals VNDA:US USD 533.71M 14.42M
Vertex Pharmaceuticals VRTX:US USD 12.97B 269.1M